Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

25.98
+0.03000.12%
Volume:13.58M
Turnover:352.22M
Market Cap:147.71B
PE:19.79
High:26.15
Open:26.00
Low:25.76
Close:25.95
52wk High:28.75
52wk Low:22.81
Shares:5.69B
Float Shares:5.68B
Volume Ratio:0.46
T/O Rate:0.24%
Dividend:1.72
Dividend Rate:6.62%
EPS(TTM):1.31
EPS(LYR):1.36
ROE:8.31%
ROA:5.69%
PB:1.64
PE(LYR):19.04

Loading ...

BUZZ-Pfizer's India unit drops on quarterly profit fall

Reuters
·
May 13

Pfizer PROTAC Licensing Deal With Rigel Adds Royalties To Valuation Story

Simply Wall St.
·
May 13

There's an estrogen-patch shortage - but these other menopause treatments can help

Dow Jones
·
May 13

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

TIPRANKS
·
May 13

BUZZ-U.S. STOCKS ON THE MOVE-Tyler Technologies, Autodesk, Illumina

Reuters
·
May 13

Pfizer Ltd March-Quarter Net Profit 2 Bln Rupees

Reuters
·
May 12

BUZZ-U.S. STOCKS ON THE MOVE-Under Armour, C3 AI, Rigel Pharma

Reuters
·
May 12

Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market

Dow Jones
·
May 12

Rigel licenses breast cancer drug VEPPANU from Arvinas, Pfizer for USD 70 million

Reuters
·
May 12

Arvinas Inc - and Pfizer to Receive $85 Mln in Upfront and Transition Payments

THOMSON REUTERS
·
May 12

Arvinas Inc - and Pfizer Eligible for up to $320 Mln in Milestone Payments and Tiered Royalties

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter Into a Transaction With Rigel Pharmaceuticals for the Exclusive Global Rights of Veppanu (Vepdegestrant)

THOMSON REUTERS
·
May 12

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

GlobeNewswire
·
May 12

If AI Reshapes Healthcare, These Three Stocks Could Lead

Simply Wall St.
·
May 12

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Mettler-Toledo (MTD)

TIPRANKS
·
May 11

BridgeBio says acoramidis cuts outpatient worsening heart failure risk 41% in Phase 3 trial

Reuters
·
May 11

Analysts Have Conflicting Sentiments on These Healthcare Companies: CSL (OtherCMXHF), Roche Holding AG (OtherRHHVF) and Pfizer (PFE)

TIPRANKS
·
May 11

What Pfizer (PFE)'s Earnings Beat, Reaffirmed Guidance and Oncology Wins Mean For Shareholders

Simply Wall St.
·
May 10

Pfizer Juggles Cancer Setbacks and Lyme Vaccine Push

TIPRANKS
·
May 09

Mixed options sentiment in Pfizer with shares down 1.52%

TIPRANKS
·
May 09